Comparison of Two Antacid Preparations on Intragastric Acidity – A Two-Centre Open Randomised Cross-Over Placebo-Controlled Trial

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Digestion

• Publication date

  2007-05-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000102627PMID 17496418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease

  2004cited by this paper
• Heartburn in primary care: problems below the surface

  2004cited by this paper
• Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn

  2002cited by this paper
• Comparison of the effect of the antacid Rennie versus low‐dose H2‐receptor antagonists (ranitidine, famotidine) on intragastric acidity

  1998cited by this paper
• Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.

  1996cited by this paper
• Pros and cons of over-the-counter availability of histamine2-receptor antagonists.

  1993cited by this paper
• Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.

  1993cited by this paper
• Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists.

  1985cited by this paper

• Prospective uncontrolled clinical study shows rapid and long lasting relief of heartburn and acid related gastric discomfort with Refluthin

  2025cites this paper
• A combination of carbonates and Opuntia ficus-indica extract protects esophageal cells against simulated acidic and non-acidic reflux in vitro

  2024cites this paper
• Preparation of a novel antibacterial magnesium carbonate coating on a titanium surface and its in vitro biocompatibility

  2024cites this paper
• Antacids revisited: review on contemporary facts and relevance for self-management

  2022cites this paper
• The features of GERD pharmacotherapy

  2021cites this paper
• STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF SIMETHICONE, DOMPERIDONE, MAGALDRATE AND SODIUM ALGINATE: APPLICATION TO SYRUP FORMULATION

  2021cites this paper
• Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease

  2020cites this paper
• Impact of acid-reducing agents on gastrointestinal physiology and design of biorelevant dissolution tests to reflect these changes.

  2019cites this paper
• Рекомендации Российской гастроэнтерологической ассоциациии Ассоциации колопроктологов России по диагностике и лечению взрослых больных дивертикулярной болезнью ободочной кишки

  2016cites this paper
• Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis.

  2015cites this paper
• Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms

  2013cites this paper
• Liquid antacids: A comparative study on palatability and cost effectiveness

  2012cites this paper
• Doença do refluxo gastroesofágico: tratamento não farmacológico

  2011cites this paper
• Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole

  2011cites this paper
• Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus.

  2010cites this paper
• Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non‐erosive reflux disease

  2009cites this paper
• Gastroesophageal Reflux Disease (GERD) and Irritable Bowel Syndrome (IBS)—Is It One Disease or an Overlap of Two Disorders?

  2009cites this paper
• Symptom Evaluation in Gastroesophageal Reflux Disease

  2008cites this paper
• Proton pump inhibitors: an update of their clinical use and pharmacokinetics

  2008cites this paper